An Introduction to Canaloplasty with Ike Ahmed and Ticiana de Francesco

MIGS was developed to keep procedures noninvasive and surgically safe while leaving scope for repeated treatment in the future if needed. Glaucoma experts Ike Ahmed and Ticiana de Francesco go live from the floor of AAO 2022 with a conversation on canaloplasty and the iTrack Advance in the early treatment of glaucoma.

Canaloplasty is best indicated for those in the early stages of the disease with a relatively uncompromised distal outflow. This early intervention keeps the physiology intact and gets patients back to their routines as quickly as possible. The iTrack Advance is the next generation of Nova Eye’s canaloplasty devices designed for increased ease of use for surgeons and represents the continued shift away from glaucoma therapeutics and toward early, minimally invasive surgical procedures.